Andrew J Gifford Selected Research

COVID-19

1/2023

Improved local diagnosis of focal hyperinsulinism in the COVID-19 era by interstate radiopharmaceutical transport.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew J Gifford Research Topics

Disease

19	Neoplasms (Cancer) 09/2023 - 11/2015
12	Neuroblastoma 11/2021 - 11/2015
2	Diffuse Intrinsic Pontine Glioma 03/2024 - 01/2017
2	Glioma (Gliomas) 01/2023 - 01/2017
1	Hyperinsulinism (Hyperinsulinemia) 01/2023
1	COVID-19 01/2023
1	Rheumatoid Arthritis 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019
1	Leukemia 12/2019
1	Carcinogenesis 11/2019
1	Critical Illness (Critically Ill) 01/2019
1	Hypertrophy 09/2018
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Brain Stem Neoplasms (Brain Stem Tumor) 01/2017
1	Cystic Fibrosis (Mucoviscidosis) 02/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2017
3	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2020
3	ChromatinIBA 01/2021 - 11/2015
2	dipinacoline glutamateIBA 03/2024 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2023
2	CBLC137IBA 01/2021 - 11/2015
2	PanobinostatIBA 01/2021 - 01/2017
2	EnzymesIBA 01/2020 - 01/2019
2	CrizotinibIBA 01/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2017
2	N-Myc Proto-Oncogene ProteinIBA 11/2019 - 09/2018
1	Coloring Agents (Dyes)IBA 09/2023
1	RadiopharmaceuticalsIBA 01/2023
1	Histones (Histone)IBA 01/2023
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Auranofin (Ridaura)FDA Link 01/2021
1	Nucleosomes (Nucleosome)IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Drug CombinationsIBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2020
1	Phosphotransferases (Kinase)IBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 10/2020
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	StathminIBA 01/2020
1	AMP-Activated Protein KinasesIBA 01/2020
1	VTP50469IBA 12/2019
1	Oncogene Proteins (Oncogene Protein)IBA 11/2019
1	Eflornithine (Ornidyl)FDA Link 01/2019
1	Heavy Chain Fusion Regulatory Protein 1IBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	SpermidineIBA 01/2019
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2019
1	PolyaminesIBA 01/2019
1	CationsIBA 01/2019
1	SteroidsIBA 12/2018
1	DesminIBA 09/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2017
1	ivacaftorIBA 02/2016
1	Histone ChaperonesIBA 11/2015
1	Octreotide (Sandostatin)FDA LinkGeneric 07/2007

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2019
3	Precision Medicine 06/2023 - 11/2020
3	Drug Therapy (Chemotherapy) 01/2019 - 11/2015
2	Immunotherapy 01/2023 - 01/2021
1	Combined Modality Therapy 01/2021
1	Transplantation 01/2021
1	Aftercare (After-Treatment) 02/2016
1	Pancreatectomy 07/2007